1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends

EpiCast Report: Gastric Cancer - Epidemiology Forecast to 2024

  • October 2015
  • 65 pages
  • GlobalData
Report ID: 3389018

Summary

Table of Contents

Search Inside

EpiCast Report: Gastric Cancer - Epidemiology Forecast to 2024

Summary

Gastric cancer, also called stomach cancer, is a multifactorial disease that starts in the tissues lining the stomach. Gastric cancer usually begins in cells in the inner layer of the stomach and tends to develop slowly into the outer layer over many years. In the early stages of gastric cancer, the affected individuals exhibit symptoms such as indigestion and stomach discomfort that require little medical attention and therefore, most of the cases remain undetected at the initial stages of the disease. Gastric cancer typically affects elderly individuals, ages 55 years and older, and peaks in the seventh decade of life and is twice as common in men as in women.

In 2014, there were a total of 312,520 diagnosed incident cases of gastric cancer in the 8MM. GlobalData epidemiologists forecast that the diagnosed incident cases of gastric cancer in the 8MM will increase to 364,518 cases by 2024 at an Annual Growth Rate (AGR) of 1.66%. In the 8MM, urban China had the highest number of diagnosed incident cases (134,968 cases) in 2014, and is expected to grow to 177,015 cases by 2024 at a high AGR of 3.12%.

GlobalData epidemiologists’ forecast for gastric cancer is supported by at least 10 years of historical data obtained from international cancer organizations, country-specific government sources, and peer-reviewed studies. The forecast of incident gastric cancer cases were based on detailed age-specific and sex-specific trends in incidence in each of the 8MM. This forecast provides detailed case-segmentation of the gastric cancer patient pool for each country by age, sex, and stage at diagnosis. Additionally, GlobalData’s analysis provides diagnosed incident cases of GEJ cancer and segmentation of diagnosed gastric cancer incident cases by cellular type and HER2 status. The forecast is driven by a thorough analysis of historical data. The forecast methodology was also consistent across all the 8MM, thereby allowing for a meaningful comparison of the forecast diagnosed incident and five-year diagnosed prevalent cases of gastric cancer across the 8MM.

Scope

- The Gastric Cancer EpiCast Report provides an overview of the risk factors, comorbidities, and global trends for gastric cancer in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and urban China). It includes a 10-year epidemiological forecast of the diagnosed incident cases of gastric cancer, gastroesophageal junction cancer, gastric adenocarcinoma, and the five-year diagnosed prevalent cases of gastric cancer segmented by age and sex in these markets. In addition this report provides further segmentation of gastric cancer by stage at diagnosis, cellular type, and human epidermal growth factor receptor status.
- The gastric cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Gastric Cancer EpiCast series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global gastric cancer market.
- Quantify patient populations in the global gastric cancer market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for gastric cancer therapeutics in each of the markets covered.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Gastric Cancer  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • March 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Gastric Cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Global Gastric Cancer Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • April 2017
  • by Currentpartnering

Provides understanding and access to the gastric cancer partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Gastric Cancer Partnering Terms ...

The 2018-2023 World Outlook for Gastric Cancer Diagnostics, Screenings, and Treatments

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for gastric cancer diagnostics, screenings, and treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.